← Leaderboards
John A Rathmacher
Metabolic Technologies, Inc.
$4,693,692
Attributed
$6,566,425
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,566,425 · 9
By mechanism
R42$3,088,886 · 1
R44$2,454,495 · 2
R41$656,580 · 2
R43$350,477 · 3
P41$15,987 · 1
Top collaborators
- James D West4 shared
- Keith T Wilson1 shared
Others in their field
Top investigators on “Metabolic”
- David M Nathan · Massachusetts Institute Of Technology$157,845,616
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$144,157,234
- Judith S. Currier · University Of California Los Angeles$141,260,706
- John M Lachin · George Washington University$139,991,329
- Randall J Bateman · Washington University$124,168,384
- Carol Nesel · Westat$116,355,411
Research focus
MetabolicProteinsLysineAdductPreventAnimalsPublishingLiteratureClinical TrialsEffectivenessSafetyBaseFunctional DisorderReactive Oxygen SpeciesLifeAffectAmericanDisease ProgressionBloodPlasmaAdultPhase 1 StudyIn VivoAge Related
Grant awards (17)
2-HOBA for Treatment of Pulmonary Hypertension$957,913
R42 · FY2025 · HL · contact PI
2-HOBA for Treatment of Pulmonary Hypertension$957,913
R42 · FY2024 · HL · contact PI
2-HOBA for Treatment of Pulmonary Hypertension$1,173,060
R42 · FY2023 · HL · contact PI
Efficacy of an Electrophile Scavenger in the Prevention of Gastrointestinal Inflammatory Carcinogenesis$400,000
R41 · FY2021 · CA · contact PI
2-HOBA for Treatment of Pulmonary Hypertension$256,580
R41 · FY2021 · HL · contact PI
2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans$605,216
R44 · FY2017 · AG · contact PI
2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans$150,636
R44 · FY2017 · AG · contact PI
Nutritional Intervention for Age-Related Muscular Function and Strength Losses$97,745
R44 · FY2017 · AG · contact PI
2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans$78,421
R44 · FY2017 · AG · contact PI
2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans$672,479
R44 · FY2016 · AG · contact PI
Nutritional Intervention for Age-Related Muscular Function and Strength Losses$374,999
R44 · FY2016 · AG · contact PI
Nutritional Intervention for Age-Related Muscular Function and Strength Losses$374,999
R44 · FY2014 · AG · contact PI
Gamma-ketoaldehyde scavengers for alcoholic liver disease$151,587
R43 · FY2014 · AA · contact PI
Nutritional Intervention for Age-Related Muscular Function and Strength Losses$100,000
R44 · FY2010 · AG · contact PI
BODY PROTEIN METABOLISM &NUTRITION IN AIDS WASTING$15,987
P41 · FY2004 · RR
Adjuvant Nutrition for Critically III Trauma Patients$99,990
R43 · FY2003 · DK
BODY PROTEIN METABOLISM AND NUTRITION IN AIDS-WASTING$98,900
R43 · FY2000 · AI